L T Hsiao

Summary

Affiliation: Taipei Veterans General Hospital
Country: Taiwan

Publications

  1. doi request reprint Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma
    Liang Tsai Hsiao
    Division of Hematology and Oncology, Department of Medicine, Taipei, Taiwan
    Eur J Haematol 88:159-66. 2012
  2. ncbi request reprint Hepatitis B infection in haematopoietic stem cell transplantation: still unresolved
    L T Hsiao
    Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Hong Kong Med J 15:42-4. 2009
  3. ncbi request reprint Graft-versus-T-cell non-Hodgkin's lymphoma effect
    Liang Tsai Hsiao
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang Ming University School of Medicine, Taipei, Taiwan
    Int J Hematol 83:193. 2006
  4. doi request reprint Impact of Port-A-Cath device management in cancer patients with candidaemia
    Y C Lai
    Division of Haematology and Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    J Hosp Infect 82:281-5. 2012
  5. ncbi request reprint Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil
    J T Lin
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec 2, Shi Pai Road, Taiwan
    Ann Hematol 81:723-6. 2002
  6. ncbi request reprint Haematopoietic stem cell transplantation in Taiwan: past, present, and future
    P M Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taiwan
    Hong Kong Med J 15:13-6. 2009
  7. doi request reprint Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients
    C Y Liu
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    Bone Marrow Transplant 46:1231-9. 2011
  8. ncbi request reprint Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation
    M Y Lee
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan
    Eur J Haematol 74:152-7. 2005
  9. ncbi request reprint Relapse of Graves' disease after successful allogeneic bone marrow transplantation
    L T Hsiao
    Division of Medical Oncology, Taipei Veterans General Hospital, National Yang-Ming University, No. 201 Shih-Pai Road, Sec. 2, Taipei 112, Taiwan, ROC
    Bone Marrow Transplant 28:1151-3. 2001
  10. ncbi request reprint Current status of hematopoietic stem cell transplantation in Taiwan
    P M Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang Ming University School of Medicine, Taiwan
    Bone Marrow Transplant 42:S133-S136. 2008

Collaborators

Detail Information

Publications41

  1. doi request reprint Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma
    Liang Tsai Hsiao
    Division of Hematology and Oncology, Department of Medicine, Taipei, Taiwan
    Eur J Haematol 88:159-66. 2012
    ..However, the prognostic impact of eGFR(MDRD) at diagnosis of MM is not well studied, particularly its use in conjunction with the International Staging System (ISS)...
  2. ncbi request reprint Hepatitis B infection in haematopoietic stem cell transplantation: still unresolved
    L T Hsiao
    Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Hong Kong Med J 15:42-4. 2009
    ..It deserves additional effort to overcome and also presents a chance to elucidate underlying mechanisms of HBV immunity, which are not easily studied in non-HSCT setting...
  3. ncbi request reprint Graft-versus-T-cell non-Hodgkin's lymphoma effect
    Liang Tsai Hsiao
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang Ming University School of Medicine, Taipei, Taiwan
    Int J Hematol 83:193. 2006
  4. doi request reprint Impact of Port-A-Cath device management in cancer patients with candidaemia
    Y C Lai
    Division of Haematology and Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    J Hosp Infect 82:281-5. 2012
    ....
  5. ncbi request reprint Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil
    J T Lin
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec 2, Shi Pai Road, Taiwan
    Ann Hematol 81:723-6. 2002
    ..To our knowledge, this is the first report of using MMF in treating MDS complicated by AIHA. MMF might be considered as a salvage therapy for patients with refractory anemia complicated by AIHA...
  6. ncbi request reprint Haematopoietic stem cell transplantation in Taiwan: past, present, and future
    P M Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taiwan
    Hong Kong Med J 15:13-6. 2009
    ..With the establishment of professional association and patient supportive groups, we hope we can fully improve our daily practice and clinical as well as basic research in HSCT...
  7. doi request reprint Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients
    C Y Liu
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    Bone Marrow Transplant 46:1231-9. 2011
    ..Levofloxacin-based prophylaxis, albeit providing similar efficacy to non-levofloxacin-containing regimens, may be associated with increased antimicrobial resistance...
  8. ncbi request reprint Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation
    M Y Lee
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan
    Eur J Haematol 74:152-7. 2005
    ..We conclude that non-myeloablative allogeneic HSCT may apply a better transplant choice in patients who need special concern with post-transplant pulmonary function changes...
  9. ncbi request reprint Relapse of Graves' disease after successful allogeneic bone marrow transplantation
    L T Hsiao
    Division of Medical Oncology, Taipei Veterans General Hospital, National Yang-Ming University, No. 201 Shih-Pai Road, Sec. 2, Taipei 112, Taiwan, ROC
    Bone Marrow Transplant 28:1151-3. 2001
    ..Thus, allogeneic BMT may facilitate relapses in autoimmune diseases as well as alleviating them...
  10. ncbi request reprint Current status of hematopoietic stem cell transplantation in Taiwan
    P M Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang Ming University School of Medicine, Taiwan
    Bone Marrow Transplant 42:S133-S136. 2008
    ..In conclusion, HSCT has been successfully adapted to routine clinical care in Taiwan. Several important findings contributing to the progress of HSCT in the past two decades have also been noticed on this island...
  11. doi request reprint High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan
    M H Chen
    Faculty of Medicine, National Yang Ming University, Taipei, Taiwan, ROC
    Bone Marrow Transplant 46:567-72. 2011
    ..Moreover, because of the relatively long latency in developing secondary carcinoma, extended follow-up is required for a thorough understanding of the incidence and characteristics of secondary carcinoma after HSCT...
  12. doi request reprint Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome
    C Y Liu
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    J Infect 58:154-60. 2009
    ..A second object was to determine whether early CVC removal would benefit a subset of cancer patients...
  13. ncbi request reprint Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexa
    P M Chen
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    Leuk Lymphoma 42:207-14. 2001
    ..Although alteration of the p53 gene is rare for low-grade ocular MALT lymphoma, its role in disease progression merits further research...
  14. ncbi request reprint Adult T-cell leukaemia/lymphoma can mimic other lymphomas in a non-endemic area: dilemmas in diagnosis and treatment
    C T Huang
    Division of Haematology and Oncology, Taipei Veterans General Hospital, Taipei, Taiwan Division of Haematology and Oncology, Department of Medicine, Yang Ming Branch of Taipei City Hospital, Taipei, Taiwan National Yang Ming University School of Medicine, Taipei, Taiwan
    Intern Med J 44:374-83. 2014
    ..The diagnosis of Adult T-cell leukaemia/lymphoma (ATL) in non-endemic regions is challenging...
  15. pmc How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?
    H N Lin
    1 Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan 2 Division of Hematology and Oncology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
    Blood Cancer J 2:e93. 2012
    ..This study also supported the role of HSCT in patients with high-risk or refractory PTCL or NKTCL...
  16. ncbi request reprint Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan
    L Y Bai
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and National Yang Ming University, 201, Sec 2, Shih Pai Road, 112 Taipei, Taiwan
    Ann Hematol 83:38-43. 2004
    ..040). In conclusion, SAA patients receiving HSCT have good long-term survival. The low incidence of acute GVHD in our patients may be related to ethnicity...
  17. doi request reprint A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone
    J R Y Wang
    Division of Haematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    J Clin Pharm Ther 35:733-6. 2010
    ..Either steroid or imatinib mesylate alone failed to achieve complete haematological response. A synergistic effect of imatinib and steroid is postulated...
  18. ncbi request reprint Acute graft-versus-host disease of the lung with atypical presentation
    Peng Chan Lin
    Department of Medical Oncology, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan, ROC
    Int J Hematol 84:1. 2006
  19. ncbi request reprint Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia
    Jin Hwang Liu
    Division of Medical Oncology and Hematology Taipei Veterans General Hospital and National Yang Ming University School of Medicine Taipei Taiwan
    Leuk Lymphoma 45:2419-25. 2004
    ..These results suggest that the expression level of cyclin D1 RNA in bone marrow cells is predictive of the phase evolution in CML and may be helpful in treatment decision-making...
  20. ncbi request reprint Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma
    Po Min Chen
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, No 201 Shih Pai Road, Section 2, Taipei 112, Taiwan, R O C
    Oncol Rep 11:349-56. 2004
    ..Our result indicates that abnormal FHIT mRNA expression is noted frequently in NHL cell lines and a certain proportion of NHL patients, and decreased FHIT protein expression indicates a significantly worse prognosis in DLBCLs...
  21. ncbi request reprint Acute polymyositis after donor lymphocyte infusion
    Peng Chan Lin
    Department of Medical Oncology, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan
    Eur J Haematol 74:166-8. 2005
    ..Acute polymyositis developed following DLI 22 d later. The clinical presentation of polymyositis is compatible with a manifestation of acute GVHD following DLI. It also responds to the treatment of steroid and CsA...
  22. ncbi request reprint Superior vena cava syndrome and hypercalcaemia in a patient with a primary mediastinal B-cell lymphoma secreting parathyroid hormone-related protein
    Liang Tsai Hsiao
    Department of Pathology, Taipei Veterans General Hospital, Taiwan
    Br J Haematol 119:1. 2002
  23. pmc Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
    C H Hsu
    Department of Oncology, National Taiwan University Hospital, 7 Chung Shan South Road, Taipei, Taiwan
    Br J Cancer 102:981-6. 2010
    ..This multicentre phase II study involving patients from several Asian countries sought to evaluate the safety and efficacy of bevacizumab plus capecitabine in this population...
  24. doi request reprint Diffusion capacity predicts long-term survival after allogeneic bone marrow transplantation for acute lymphoblastic leukemia
    Peter Mu Hsin Chang
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    J Chin Med Assoc 71:234-40. 2008
    ..The aim of this study was to evaluate changes in pulmonary function measures as predictors of outcome in acute lymphoblastic leukemia (ALL) patients after myeloablative allogeneic bone marrow transplantation (BMT)...
  25. ncbi request reprint Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia
    Ming Huang Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Int J Hematol 86:275-81. 2007
    ..Further larger-scale randomized clinical trials are warranted to clarify the efficacy of this treatment regimen...
  26. ncbi request reprint Intravenous busulfan as preparative regimen in pediatric patients receiving hematopoietic stem cell transplantation: the preliminary experience in Taiwan
    Ming Yang Lee
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, Taiwan, ROC
    J Chin Med Assoc 67:117-22. 2004
    ..In this study, we aimed to evaluate the efficacy and complications of IV busulfan in pediatric patients...
  27. ncbi request reprint High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan
    Po Min Chen
    Division of Medical Oncology, Department of Medicine, Taipei Veteran General Hospital, Taipei, Taiwan, Republic of China
    Cancer Invest 24:223-8. 2006
    ..0001). Prospective studies are needed to determine the prevalence of SV40 infections in our and other human populations and to explore the means of transmission of the virus...
  28. ncbi request reprint Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients
    Peng Chan Lin
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang Ming University, School of Medicine, Taipei 112, Taiwan
    Int J Hematol 81:349-51. 2005
    ..We suggest that the duration of prophylactic use of lamivudine in chronic HBV carriers receiving HSCT be prolonged until the patient's immune system has been reconstituted...
  29. ncbi request reprint Lymphoma presenting as Sister Mary Joseph's nodule sparing intra-abdominal involvement
    Ying Ih Shih
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Int J Hematol 83:194. 2006
  30. ncbi request reprint High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma
    Liang Tsai Hsiao
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taiwan
    Eur J Haematol 70:282-9. 2003
    ..The pathogenic role of HGF in NHL patients was further highlighted by a modest expression of HGF in most of the diffuse large B cell lymphoma...
  31. doi request reprint High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma
    Ming Huang Chen
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Ann Hematol 87:475-80. 2008
    ..B cell NHL patients, even HBsAg-negative B cell NHL patients, but not T cell NHL patients, have a higher incidence of HBV infection than patients with solid tumors. Our findings support the etiologic role of HBV infection in B cell NHL...
  32. ncbi request reprint Transplantation of related histocompatible marrow and peripheral blood stem cells in a patient with severe combined immunodeficiency and disseminated BCG infection
    Giun Yi Hung
    Department of Pediatrics, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan, ROC
    J Chin Med Assoc 66:72-5. 2003
    ..The patient finally expired because of failure to achieve a functioning immune system after BMT and septic shock...
  33. ncbi request reprint Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital
    Li Yuan Bai
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Cancer 98:1188-95. 2003
    ..The annual incidence of non-Hodgkin lymphoma (NHL) has increased over the past two decades in all age groups, including the elderly. Establishing guidelines for proper care for this segment of the population requires further information...
  34. ncbi request reprint Delayed rejection after initial engraftment in non-myeloablative bone marrow transplantation
    Muh Hwa Yang
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    J Chin Med Assoc 66:682-8. 2003
    ..The patient expired on day +151. We recommend that the suitability of NM-BMT for high-risk patients such as unrelated-donor BMT and elder recipients needs further studies to confirm...
  35. ncbi request reprint Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients
    Liang Tsai Hsiao
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Biol Blood Marrow Transplant 12:84-94. 2006
    ..016-0.908; P = .040). In conclusion, extended lamivudine therapy is safe and effective for the prevention of HBV reactivation in an HSCT setting and significantly decreases reactivation hepatitis after transplantation...
  36. ncbi request reprint Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma
    Muh Hwa Yang
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, No 201 Sec 2 Shih Pai Rd, Taipei 112, Taiwan
    Oncol Rep 13:503-8. 2005
    ..It is also a factor of poor prognosis in DLBCL, especially for high-intermediate risk category...
  37. ncbi request reprint Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP
    Peng Chan Lin
    Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Ann Hematol 86:95-100. 2007
    ..Adding rituximab to the standard CHOP regimen in elderly DLBCL patients might increase the incidence of fungal infection especially in those older than 80 years old...
  38. ncbi request reprint Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation
    Ming Yang Lee
    Division of Hemato Oncology, Department of Medicine, Chia Yi Christian Hospital, Chia Yi, Taiwan, ROC
    Ann Hematol 87:285-9. 2008
    ..7% vs 0%, p = 0.131, Fisher exact test, two-sided). The NHL patients receiving rituximab therapy had higher risk to develop CMV infectious complications after autologous HSCT...
  39. ncbi request reprint Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation
    Po Min Chen
    Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital Department of Medicine, Taipei, Republic of China
    Transplantation 74:182-8. 2002
    ..This study elucidates the profiles for hepatitis B virus (HBV) reactivation and genetic mutation of the core promoter and precore regions for HBV-carriers receiving hematopoietic stem cell transplantation (HSCT)...
  40. ncbi request reprint Fatal early-onset epstein-barr virus-associated posttransplantation lymphoproliferative disease after successful adult dual-unit umbilical cord blood transplantation
    Say Bee Poh
    Biol Blood Marrow Transplant 11:732-3. 2005
  41. ncbi request reprint Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy
    Yu Hui Hu
    Eur J Haematol 78:176-7. 2007